Total Funding
86
59
Total FundingGrant raised
Growth Score 86 in past quarter
-4 pts
Heat Score 59 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
120468
Biointaxis is a biotechnology company that develops and offers advance technology products for neurodegenerative diseases.
- Antoni Matilla Dueñas: Co-Founder and Director
- Ivelisse Sanchez: Co-Founder and Chief Scientific Officer
About the Company
Biointaxis is a genomic treatment and technology development company. The current lead program develops a gene therapy treatment for Friedreich ataxia, a rare, inherited, progressive neurodegenerative disease that typically affects teenagers and young adults. They reestablished the neurological functions in mice models of friedreich ataxia.